Virus-like siRNA construct dynamically responsive to sequential microenvironments for potent RNA interference.

Area of Science:

• Biotechnology
• Nanotechnology
• Molecular Biology

Background:

• Cytoplasmic delivery of therapeutic nucleic acids, such as small interfering RNA (siRNA), for gene knockdown remains a significant challenge in developing effective therapies.
• Natural viruses possess inherent mechanisms to overcome biological barriers, making them attractive models for designing synthetic delivery systems.

Purpose of the Study:

• To develop synthetic siRNA delivery vehicles that mimic viral vector functionalities for systemic anti-tumor RNAi therapy.
• To overcome biological obstacles encountered during systemic delivery and achieve precise gene knockdown in tumor cells.

Main Methods:

• Engineered multifunctional nanoparticles incorporating RGD ligands for targeted tumor cell internalization.
• Designed pH-responsive nanoparticles that detach PEGylation in acidic endosomal compartments, exposing lytic components.
• Utilized glutathione-responsive siRNA release in the cytosol for potent RNAi activation.

Main Results:

• The virus-mimicking delivery vehicles demonstrated efficient internalization into tumor cells via RGD-mediated endocytosis.
• Acid-labile PEGylation detachment and subsequent endosomal membrane disruption facilitated siRNA translocation into the cytosol.
• Intracellular glutathione triggered siRNA release, leading to effective RNA interference and significant anti-tumor efficacy in vivo.

Conclusions:

• The developed virus-mimicking platform effectively addresses challenges in systemic RNAi delivery for cancer therapy.
• This versatile platform shows significant anti-tumor activity through systemic administration of anti-angiogenic RNAi payloads.
• The study highlights promising therapeutic potential for this nanodelivery system in various medical applications.